北美膀胱过度活动症治疗市场预测至 2028 年 – COVID-19 影响和区域分析 – 按药物疗法（抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱内滴注）和疾病类型（特发性膀胱过度活动症和神经源性膀胱）
No. of Pages: 146 | Report Code: BMIRE00027850 | Category: Life Sciences
No. of Pages: 146 | Report Code: BMIRE00027850 | Category: Life Sciences
增加尿失禁的流行推动北美膀胱过度活动症治疗市场
尿失禁是由于控制膀胱的肌肉和神经功能不正常而导致的膀胱控制丧失尿液通过膀胱的通道。压力性尿失禁和急迫性尿失禁是影响女性的两种常见类型的尿失禁，其中后者也称为膀胱过度活动症。美国卫生与公共服务部妇女健康办公室的数据显示，女性失禁的患病率是男性的两倍，而衰老、怀孕、分娩和更年期可能是导致这种情况的关键因素在女性中。影响肌肉和神经功能的其他一些因素包括超重、便秘或盆腔手术。据北美更年期协会 (NAMS) 统计，到 2021 年，美国 20 岁及以上女性尿失禁患病率为 17.1%，60 岁及以上女性尿失禁患病率为 38%。尿失禁可影响女性任何年龄；然而，由于更年期荷尔蒙的变化，这种情况在老年女性中更为常见。因此，泌尿相关疾病的激增直接推动了这一趋势。
北美膀胱过度活动症治疗市场概况
北美膀胱过度活动症治疗市场分为美国、加拿大和墨西哥。由于老年人口的增加以及过度活动性疾病和帕金森病的流行，2021年北美在膀胱过度活动症治疗市场中占据最大份额。据帕金森基金会称，美国约有 100 万人患有帕金森病，到 2030 年这一数字可能会达到 120 万。虽然膀胱过度活动症可发生在任何年龄，但在老年人群中相当普遍60岁以上。根据社区生活管理局的数据，2019 年美国 16% 的人口年龄在 65 岁及以上，预计到 2040 年将达到 21.6%。人口资料局 (PRB) 表示，美国 65 岁及以上人口的数量预计到 2060 年，老年人口数量将增加近一倍，从 2018 年的 5200 万增加到 9500 万。根据克利夫兰诊所组织的数据，美国约有 3300 万成年人受到膀胱过度活动症的影响。此外，John Wiley & 的一篇文章Sons, Inc. 表示，约 17% 的美国人口患有这种疾病。因此，整个地区对膀胱过度活动症治疗的需求正在增加。
北美膀胱过度活动症治疗市场细分
北美膀胱过度活动症治疗市场根据药物治疗、疾病类型、
根据药物治疗，北美膀胱过度活动症治疗市场分为抗胆碱能药物、米拉贝隆、肉毒杆菌、神经刺激和膀胱内注射灌输。米拉贝隆细分市场在 2022 年占据最大市场份额。
根据疾病类型，北美膀胱过度活动症治疗市场分为两部分分为特发性膀胱过度活动症和神经源性膀胱。到 2022 年，特发性膀胱过度活动症细分市场将占据更大的市场份额。
按国家/地区划分，北美膀胱过度活动症治疗市场为分为美国、加拿大和墨西哥。 2022 年，美国将主导市场。
AbbVie Inc; Alembic 制药有限公司；安斯泰来制药公司； Axonics 调制技术公司；科罗拉多泌尿外科协会，PLLC；远藤制药公司；久光制药有限公司；美敦力公司；辉瑞公司；和 Teva Pharmaceutical Industries Ltd 是北美膀胱过度活动症治疗市场的领先公司。
Strategic insights for North America Overactive Bladder Treatment involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 1,682.29 Million |
| Market Size by 2028 | US$ 2,059.43 Million |
| Global CAGR (2022 - 2028) | 3.4% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2028 |
| Segments Covered |
By 药物治疗
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Overactive Bladder Treatment refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Overactive Bladder Treatment Market is valued at US$ 1,682.29 Million in 2022, it is projected to reach US$ 2,059.43 Million by 2028.
As per our report North America Overactive Bladder Treatment Market, the market size is valued at US$ 1,682.29 Million in 2022, projecting it to reach US$ 2,059.43 Million by 2028. This translates to a CAGR of approximately 3.4% during the forecast period.
The North America Overactive Bladder Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Overactive Bladder Treatment Market report:
The North America Overactive Bladder Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Overactive Bladder Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Overactive Bladder Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Overactive Bladder Treatment Market
